Skip to main content
TipRanks
Go Ultimate75% OFF

Biocure Technology Inc (CURE.X) Stock Statistics & Valuation Metrics

4 Followers

Total Valuation

Biocure Technology Inc has a market cap or net worth of CAD 1.11M. The enterprise value is CAD 1.53M.

Market Cap
CAD 1.11M
Enterprise Value
CAD 1.53M

Share Statistics

Biocure Technology Inc has 20,207,005 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
20,207,005
Owned by Insiders
12.23%
Owned by Institutions
―

Financial Efficiency

Biocure Technology Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
―
Employee Count
0
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, Biocure Technology Inc had revenue of ― and earned -8,713 in profits. Earnings per share was ―.

Revenue
―
Gross Profit
―
Operating Income
-39.95K
Pretax Income
―
Net Income
-8,713
EBITDA
-8,212
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
2.01
52-Week Price Change
-31.25%
50-Day Moving Average
0.06
200-Day Moving Average
0.05
Relative Strength Index (RSI)
42.42
Average Volume (3m)
―

Important Dates

Biocure Technology Inc upcoming earnings date is Nov 30, 2026, TBA (Not Confirmed).

Last Earnings Date
Aug 27, 2026
Next Earnings Date
Nov 30, 2026
Ex-Dividend Date
―

Balance Sheet

Biocure Technology Inc has ― in cash and marketable securities with CAD 3.84M in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
CAD 3.84M
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for Biocure Technology Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
73.93%